MME and amyloidosis: Deciphering the mechanisms of regulation of the major ADEs, in particular of NEP, lead us to a conclusion that there are some common targets which can be treated simultaneously by the same compounds modulating expression of several proteins involved in amyloid clearance (for example NEP and TTR), and this can result in design of a therapeutic strategy towards improved amyloid clearance.